Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| HTCO | High-Trend International Group | $35.32 | $24.07 | 213.96% | 12.2M | $83M | $4.55$61.75 |
| YAAS | Youxin Technology | $1.53 | $0.60 | 64.36% | 137.8M | $10M | $0.75$560.00 |
| EDSA | Edesa Biotech | $11.41 | $4.15 | 57.09% | 7.9M | $61M | $0.72$11.87 |
| MANE | Veradermics | $96.30 | $28.46 | 41.95% | 2.8M | $2.5B | $17.00$101.81 |
| CRMU | Themes ETF Trust - Leverage Shares 2x Long Crml Daily ETF | $13.82 | $4.07 | 41.74% | 358K | - | $3.99$15.25 |
| SGMT | Sagimet Biosciences | $8.05 | $2.19 | 37.38% | 47.4M | $191M | $3.03$11.41 |
| SPRC | SciSparc | $8.89 | $2.20 | 32.88% | 191.7K | $3.8M | $2.98$94.50 |
| QNTM | Quantum BioPharma Ltd. | $4.60 | $0.99 | 27.42% | 1.8M | $21M | $2.07$38.25 |
| ABSI | Absci | $4.80 | $0.86 | 21.70% | 579K | $603M | $2.24$5.23 |
| RMAX | RE/MAX Holdings | $9.69 | $1.70 | 21.28% | 12.8M | $161M | $5.46$10.32 |
| QUIK | QuickLogic | $15.60 | $2.52 | 19.27% | 2M | $232M | $4.80$16.89 |
| LACG | Themes ETF Trust - Leverage Shares 2x Long Lac Daily ETF | $11.25 | $1.69 | 17.62% | 18.7K | - | $6.34$26.22 |
| CRML | Critical Metals | $13.49 | $1.98 | 17.20% | 1.2M | $1.4B | $1.29$32.15 |
| ONEG | OneConstruction Group | $6.81 | $0.99 | 17.01% | 363.9K | $93M | $0.96$13.50 |
| OGN | Organon & Co. | $13.17 | $1.91 | 16.92% | 116.5M | $2.9B | $5.69$13.25 |
| UECG | Themes ETF Trust - Leverage Shares 2x Long Uec Daily ETF | $10.51 | $1.50 | 16.66% | 48.7K | - | $6.75$15.46 |
| RVI | Robinhood Ventures Fund I | $35.25 | $4.75 | 15.57% | 951.8K | $385M | $21.00$36.06 |
| WATT | Energous | $32.46 | $4.27 | 15.15% | 642.3K | $155M | $3.62$32.63 |
| ATXG | Addentax Group | $5.50 | $0.71 | 14.82% | 66.4K | $3.7M | $3.32$27.90 |
| EUDA | Euda Health | $12.19 | $1.57 | 14.75% | 365.2K | $27M | $5.26$86.00 |
| FRMM | ETHZilla | $5.55 | $0.68 | 13.96% | 1.4M | $99M | $1.76$174.60 |
| CLIK | Click | $3.11 | $0.36 | 13.09% | 170.9K | $9.0M | $1.32$34.20 |
| FLXS | Flexsteel Industries | $54.50 | $6.30 | 13.07% | 112K | $258M | $29.38$59.95 |
| GOAI | Eva Live | $4.04 | $0.47 | 13.03% | 70.4K | $112M | $1.32$18.00 |
| LVO | LiveOne | $5.70 | $0.62 | 12.21% | 246.3K | $59M | $3.70$9.80 |
Related Articles
Featured Article
This Rare Earth Stock Just Took Control of a Massive Greenland Deposit. Is It a Buy?
Courtney Carlsen|Apr 24, 2026
Critical Metals gained control over a resource-rich project in Greenland, as Western nations look to diversify away from China.
Is Critical Metals Stock a Buy Now?
Courtney Carlsen|Mar 19, 2026
Rare-earth elements are essential for defense and modern technology, and Critical Metals could play a key role in securing these vital minerals.
Why Did Critical Metals Stock Soar 90% Last Month?
Howard Smith|Feb 3, 2026
The development stage mining company provided updates in January that generated excitement among investors.
Why Rare-Earth Stock Critical Metals Soared 108% in October
Neha Chamaria|Nov 10, 2025
Watch this rare-earth stock closely.
Is the White House About to Invest in These Lithium and Rare Earth Miners?
Matthew Benjamin|Oct 12, 2025
The U.S. government may be eyeing investments in mining companies, sending their shares higher.
Is This Healthcare Stock's 10% Yield a Steal of a Deal or Too Good to Be True?
David Jagielski, CPA|Nov 21, 2023
High-yielding stocks may be tantalizing, but they often come with risks.
Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks.
David Jagielski, CPA|Jul 21, 2023
These stocks can significantly bolster your income.
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks
David Jagielski, CPA|Jun 29, 2023
These stocks are down more than 5% this year, and now may be a good time to add them to your portfolio.
3 of the Best Value Stocks to Buy Heading Into April
David Jagielski, CPA|Mar 30, 2022
With these shares at modest valuations, you can score some cheap long-term investments.
Should Investors Hold Out Hope for bluebird bio and Merck Spinoff Organon?
Keith Speights and Brian Orelli, PhD|Jul 10, 2021
Neither healthcare stock has performed well so far this year.
